Multi-cancer & pre-cancer detection technology integrated into a global cancer registry. Our Lancor Scientific Platform is based on two disruptive innovations:

OMIS cancer screening device:     
  • Accurate

    with sensitivity & specificity ≥ 90%

  • Rapid

    test results at point of care in less than 2 minutes

  • Affordable

    total costs of screening & data reporting $20 / test

  • Portable

    and robust CE marked

Blockchain: 
  • Authenticated test results

    patient centred data records

  • Real-time automated transmission onto a global (& national) cancer registry

  • Immutable records

    incorruptible to loss, administrative errors, or medical fraud


    Real patient stories - Find cancer early

    Avril

    Thomas

    Video Interviews

    Prof. Djuro Koruga and Gopal Rao discuss OMIS (Opto Magnetic Imaging Spectroscopy) Technology in the Lancor Scientific portable screening devices.

    Chief Medical Officer Prof. Roland Schlesinger discusses some of the science behind what we are doing and our global cancer registry.

    COO Gopal Rao talks about the problems with cancer screening and how Lancor Scientific will solve the bigger picture.